AKEBIA THERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $228.6M | $259.3M | $87.3M |
| Jun 2017 | $279.8M | $336.8M | $125.4M |
| Sep 2017 | $238.7M | $338.6M | $89.6M |
| Dec 2017 | $241.7M | $364.2M | $70.2M |
| Mar 2018 | $245.6M | $442.7M | $158.2M |
| Jun 2018 | $247.9M | $413.8M | $163.5M |
| Sep 2018 | $261.3M | $403.8M | $162.4M |
| Dec 2018 | $360.6M | $996.5M | $104.6M |
| Mar 2019 | $324.4M | $890.8M | $62.7M |
| Jun 2019 | $304.2M | $823.5M | $87.2M |
| Sep 2019 | $327.7M | $795.2M | $122.9M |
| Dec 2019 | $376.4M | $771.2M | $147.4M |
| Mar 2020 | $391.4M | $787.7M | $115.4M |
| Jun 2020 | $374.9M | $745.2M | $245.4M |
| Sep 2020 | $358.2M | $676.1M | $169.3M |
| Dec 2020 | $396.5M | $644.1M | $228.7M |
| Mar 2021 | $414.8M | $628.7M | $252.8M |
| Jun 2021 | $437.2M | $611.9M | $247.0M |
| Sep 2021 | $465.1M | $602.3M | $207.2M |
| Dec 2021 | $455.3M | $529.3M | $149.8M |
| Mar 2022 | $519.2M | $541.8M | $174.6M |
| Jun 2022 | $470.9M | $529.9M | $143.9M |
| Sep 2022 | $436.0M | $444.3M | $144.8M |
| Dec 2022 | $350.8M | $356.1M | $90.5M |
| Mar 2023 | $300.1M | $280.9M | $57.0M |
| Jun 2023 | $280.5M | $253.7M | $53.6M |
| Sep 2023 | $274.4M | $235.0M | $46.5M |
| Dec 2023 | $272.3M | $241.7M | $42.9M |
| Mar 2024 | $252.7M | $225.5M | $42.0M |
| Jun 2024 | $254.0M | $220.2M | $39.5M |
| Sep 2024 | $257.5M | $207.1M | $34.0M |
| Dec 2024 | $269.9M | $220.7M | $51.9M |
| Mar 2025 | $285.6M | $310.2M | $113.4M |
| Jun 2025 | $316.4M | $345.6M | $137.3M |
| Sep 2025 | $322.6M | $364.2M | $166.4M |
| Dec 2025 | $344.0M | $376.6M | $184.8M |
| Mar 2026 | $335.1M | $362.5M | $162.6M |
| Jun 2026 | $324.6M | $349.7M | $155.5M |